−1 610KRW
−42.26 BKRW
11.41 BKRW
27.77 M
About CLINOMICS
Sector
Industry
Headquarters
Ulsan
Website
Employees (FY)
59
Founded
2011
ISIN
KR7352770002
FIGI
BBG00XRTSRJ4
Clinomics, Inc. engages in the development and commercializing cancer and disease early diagnosis technology services. Its products and services include COVID-19 test kits, liquid biopsy and precision medicine, health care, and big data. The company was founded on June 21, 2011 and is headquartered in Ulsan, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 352770 is 1 750 KRW — it has increased by 1.10% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange CLINOMICS stocks are traded under the ticker 352770.
Yes, you can track CLINOMICS financials in yearly and quarterly reports right on TradingView.
Like other stocks, 352770 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CLINOMICS stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 59.00 employees. See our rating of the largest employees — is CLINOMICS on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CLINOMICS EBITDA is −30.34 B KRW, and current EBITDA margin is −265.94%. See more stats in CLINOMICS financial statements.